Is AIGB34 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6
Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of AIGB34 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate AIGB34's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate AIGB34's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for AIGB34?
Key metric: As AIGB34 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for AIGB34. This is calculated by dividing AIGB34's market cap by their current
earnings.
What is AIGB34's PE Ratio?
PE Ratio
12.6x
Earnings
US$3.81b
Market Cap
US$48.12b
AIGB34 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: AIGB34 is expensive based on its Price-To-Earnings Ratio (12.6x) compared to the Global Insurance industry average (11.3x).
Price to Earnings Ratio vs Fair Ratio
What is AIGB34's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
AIGB34 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
12.6x
Fair PE Ratio
n/a
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate AIGB34's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.